Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Meloxicam Market Growth 2022-2028

  • LP 4832810
  • 123 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Meloxicam will have significant change from previous year. According to our (LP Information) latest study, the global Meloxicam market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Meloxicam market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Meloxicam market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Meloxicam market, reaching US$ million by the year 2028. As for the Europe Meloxicam landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Meloxicam players cover Boehringer Ingelheim, Baudax, Perrigo, and Recro Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Meloxicam market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

by Ingredient

Combination Drugs

Prescribed Drugs

by Route

Oral

Intravenou

by Dosage Form

Tablets

Capsule

Granules

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Rheumatoid Arthritis

Osteoarthritis

Soft Tissue Inflammation

Traumatic Pain

Post-Operative Pain

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Boehringer Ingelheim

Baudax

Perrigo

Recro Pharma

Iroko Pharma

Zyla Life Sciences

Axsome Therapeutics

Orbis Biosciences

Cellix Bio

Ligand Pharma

SEDOR Pharma

Heron Therapeutics

Pacira BioSciences

Sanofi

Eurofarma Laboratorio

TerSera Therapeutics

Apotex

Yung Shin Pharmaceutical

Breckenridge Pharmaceutical

Zydus Pharmaceuticals

Unichem Pharmaceuticals

Strides Pharma

Cipla

Dr. Reddy's Laboratories

Glenmark Pharmaceuticals

Teva

PuraCap Pharmaceutical

TARO

Lupin Pharmaceuticals

Aurobindo Pharma

Shanghai Bolinger Ingelheim Pharmaceutical

Shanghai Zhaohui Pharmaceutical

Sichuan Shenghe Pharmaceutical

Ningxia Kangya Pharmaceutical

Yangtze Pharmaceutical Group

Kunshan Longdeng Ruidi Pharmaceutical

Jiangsu Yabang Epson Pharmaceutical

Jiangsu Feima Pharmaceutical Co. , Ltd

Zhejiang Xianju Pharmaceutical

Hainan All Star Pharmaceutical

Hainan Aomeihua Pharmaceutical

Hunan Mingrui Pharmaceutical

Suzhou Sinochem Pharmaceutical

Qilu Pharmaceutical

Sichuan Luye Pharmaceutical

Shandong Xinhua Pharmaceutical

Guangdong Renkang Pharmaceutical

Hainan Selike Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Meloxicam Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Meloxicam by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Meloxicam by Country/Region, 2017, 2022 & 2028

2.2 Meloxicam Segment by Type

2.2.1 Combination Drugs

2.2.2 Prescribed Drugs

2.3 Meloxicam Sales by Type

2.3.1 Global Meloxicam Sales Market Share by Type (2017-2022)

2.3.2 Global Meloxicam Revenue and Market Share by Type (2017-2022)

2.3.3 Global Meloxicam Sale Price by Type (2017-2022)

2.4 Meloxicam Segment by Application

2.4.1 Rheumatoid Arthritis

2.4.2 Osteoarthritis

2.4.3 Soft Tissue Inflammation

2.4.4 Traumatic Pain

2.4.5 Post-Operative Pain

2.4.6 Other

2.5 Meloxicam Sales by Application

2.5.1 Global Meloxicam Sale Market Share by Application (2017-2022)

2.5.2 Global Meloxicam Revenue and Market Share by Application (2017-2022)

2.5.3 Global Meloxicam Sale Price by Application (2017-2022)

3 Global Meloxicam by Company

3.1 Global Meloxicam Breakdown Data by Company

3.1.1 Global Meloxicam Annual Sales by Company (2020-2022)

3.1.2 Global Meloxicam Sales Market Share by Company (2020-2022)

3.2 Global Meloxicam Annual Revenue by Company (2020-2022)

3.2.1 Global Meloxicam Revenue by Company (2020-2022)

3.2.2 Global Meloxicam Revenue Market Share by Company (2020-2022)

3.3 Global Meloxicam Sale Price by Company

3.4 Key Manufacturers Meloxicam Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Meloxicam Product Location Distribution

3.4.2 Players Meloxicam Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Meloxicam by Geographic Region

4.1 World Historic Meloxicam Market Size by Geographic Region (2017-2022)

4.1.1 Global Meloxicam Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Meloxicam Annual Revenue by Geographic Region

4.2 World Historic Meloxicam Market Size by Country/Region (2017-2022)

4.2.1 Global Meloxicam Annual Sales by Country/Region (2017-2022)

4.2.2 Global Meloxicam Annual Revenue by Country/Region

4.3 Americas Meloxicam Sales Growth

4.4 APAC Meloxicam Sales Growth

4.5 Europe Meloxicam Sales Growth

4.6 Middle East & Africa Meloxicam Sales Growth

5 Americas

5.1 Americas Meloxicam Sales by Country

5.1.1 Americas Meloxicam Sales by Country (2017-2022)

5.1.2 Americas Meloxicam Revenue by Country (2017-2022)

5.2 Americas Meloxicam Sales by Type

5.3 Americas Meloxicam Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Meloxicam Sales by Region

6.1.1 APAC Meloxicam Sales by Region (2017-2022)

6.1.2 APAC Meloxicam Revenue by Region (2017-2022)

6.2 APAC Meloxicam Sales by Type

6.3 APAC Meloxicam Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Meloxicam by Country

7.1.1 Europe Meloxicam Sales by Country (2017-2022)

7.1.2 Europe Meloxicam Revenue by Country (2017-2022)

7.2 Europe Meloxicam Sales by Type

7.3 Europe Meloxicam Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Meloxicam by Country

8.1.1 Middle East & Africa Meloxicam Sales by Country (2017-2022)

8.1.2 Middle East & Africa Meloxicam Revenue by Country (2017-2022)

8.2 Middle East & Africa Meloxicam Sales by Type

8.3 Middle East & Africa Meloxicam Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Meloxicam

10.3 Manufacturing Process Analysis of Meloxicam

10.4 Industry Chain Structure of Meloxicam

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Meloxicam Distributors

11.3 Meloxicam Customer

12 World Forecast Review for Meloxicam by Geographic Region

12.1 Global Meloxicam Market Size Forecast by Region

12.1.1 Global Meloxicam Forecast by Region (2023-2028)

12.1.2 Global Meloxicam Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Meloxicam Forecast by Type

12.7 Global Meloxicam Forecast by Application

13 Key Players Analysis

13.1 Boehringer Ingelheim

13.1.1 Boehringer Ingelheim Company Information

13.1.2 Boehringer Ingelheim Meloxicam Product Offered

13.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boehringer Ingelheim Main Business Overview

13.1.5 Boehringer Ingelheim Latest Developments

13.2 Baudax

13.2.1 Baudax Company Information

13.2.2 Baudax Meloxicam Product Offered

13.2.3 Baudax Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Baudax Main Business Overview

13.2.5 Baudax Latest Developments

13.3 Perrigo

13.3.1 Perrigo Company Information

13.3.2 Perrigo Meloxicam Product Offered

13.3.3 Perrigo Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Perrigo Main Business Overview

13.3.5 Perrigo Latest Developments

13.4 Recro Pharma

13.4.1 Recro Pharma Company Information

13.4.2 Recro Pharma Meloxicam Product Offered

13.4.3 Recro Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Recro Pharma Main Business Overview

13.4.5 Recro Pharma Latest Developments

13.5 Iroko Pharma

13.5.1 Iroko Pharma Company Information

13.5.2 Iroko Pharma Meloxicam Product Offered

13.5.3 Iroko Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Iroko Pharma Main Business Overview

13.5.5 Iroko Pharma Latest Developments

13.6 Zyla Life Sciences

13.6.1 Zyla Life Sciences Company Information

13.6.2 Zyla Life Sciences Meloxicam Product Offered

13.6.3 Zyla Life Sciences Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Zyla Life Sciences Main Business Overview

13.6.5 Zyla Life Sciences Latest Developments

13.7 Axsome Therapeutics

13.7.1 Axsome Therapeutics Company Information

13.7.2 Axsome Therapeutics Meloxicam Product Offered

13.7.3 Axsome Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Axsome Therapeutics Main Business Overview

13.7.5 Axsome Therapeutics Latest Developments

13.8 Orbis Biosciences

13.8.1 Orbis Biosciences Company Information

13.8.2 Orbis Biosciences Meloxicam Product Offered

13.8.3 Orbis Biosciences Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Orbis Biosciences Main Business Overview

13.8.5 Orbis Biosciences Latest Developments

13.9 Cellix Bio

13.9.1 Cellix Bio Company Information

13.9.2 Cellix Bio Meloxicam Product Offered

13.9.3 Cellix Bio Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Cellix Bio Main Business Overview

13.9.5 Cellix Bio Latest Developments

13.10 Ligand Pharma

13.10.1 Ligand Pharma Company Information

13.10.2 Ligand Pharma Meloxicam Product Offered

13.10.3 Ligand Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Ligand Pharma Main Business Overview

13.10.5 Ligand Pharma Latest Developments

13.11 SEDOR Pharma

13.11.1 SEDOR Pharma Company Information

13.11.2 SEDOR Pharma Meloxicam Product Offered

13.11.3 SEDOR Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 SEDOR Pharma Main Business Overview

13.11.5 SEDOR Pharma Latest Developments

13.12 Heron Therapeutics

13.12.1 Heron Therapeutics Company Information

13.12.2 Heron Therapeutics Meloxicam Product Offered

13.12.3 Heron Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Heron Therapeutics Main Business Overview

13.12.5 Heron Therapeutics Latest Developments

13.13 Pacira BioSciences

13.13.1 Pacira BioSciences Company Information

13.13.2 Pacira BioSciences Meloxicam Product Offered

13.13.3 Pacira BioSciences Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Pacira BioSciences Main Business Overview

13.13.5 Pacira BioSciences Latest Developments

13.14 Sanofi

13.14.1 Sanofi Company Information

13.14.2 Sanofi Meloxicam Product Offered

13.14.3 Sanofi Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Sanofi Main Business Overview

13.14.5 Sanofi Latest Developments

13.15 Eurofarma Laboratorio

13.15.1 Eurofarma Laboratorio Company Information

13.15.2 Eurofarma Laboratorio Meloxicam Product Offered

13.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Eurofarma Laboratorio Main Business Overview

13.15.5 Eurofarma Laboratorio Latest Developments

13.16 TerSera Therapeutics

13.16.1 TerSera Therapeutics Company Information

13.16.2 TerSera Therapeutics Meloxicam Product Offered

13.16.3 TerSera Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 TerSera Therapeutics Main Business Overview

13.16.5 TerSera Therapeutics Latest Developments

13.17 Apotex

13.17.1 Apotex Company Information

13.17.2 Apotex Meloxicam Product Offered

13.17.3 Apotex Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Apotex Main Business Overview

13.17.5 Apotex Latest Developments

13.18 Yung Shin Pharmaceutical

13.18.1 Yung Shin Pharmaceutical Company Information

13.18.2 Yung Shin Pharmaceutical Meloxicam Product Offered

13.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Yung Shin Pharmaceutical Main Business Overview

13.18.5 Yung Shin Pharmaceutical Latest Developments

13.19 Breckenridge Pharmaceutical

13.19.1 Breckenridge Pharmaceutical Company Information

13.19.2 Breckenridge Pharmaceutical Meloxicam Product Offered

13.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Breckenridge Pharmaceutical Main Business Overview

13.19.5 Breckenridge Pharmaceutical Latest Developments

13.20 Zydus Pharmaceuticals

13.20.1 Zydus Pharmaceuticals Company Information

13.20.2 Zydus Pharmaceuticals Meloxicam Product Offered

13.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Zydus Pharmaceuticals Main Business Overview

13.20.5 Zydus Pharmaceuticals Latest Developments

13.21 Unichem Pharmaceuticals

13.21.1 Unichem Pharmaceuticals Company Information

13.21.2 Unichem Pharmaceuticals Meloxicam Product Offered

13.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Unichem Pharmaceuticals Main Business Overview

13.21.5 Unichem Pharmaceuticals Latest Developments

13.22 Strides Pharma

13.22.1 Strides Pharma Company Information

13.22.2 Strides Pharma Meloxicam Product Offered

13.22.3 Strides Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Strides Pharma Main Business Overview

13.22.5 Strides Pharma Latest Developments

13.23 Cipla

13.23.1 Cipla Company Information

13.23.2 Cipla Meloxicam Product Offered

13.23.3 Cipla Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Cipla Main Business Overview

13.23.5 Cipla Latest Developments

13.24 Dr. Reddy's Laboratories

13.24.1 Dr. Reddy's Laboratories Company Information

13.24.2 Dr. Reddy's Laboratories Meloxicam Product Offered

13.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Dr. Reddy's Laboratories Main Business Overview

13.24.5 Dr. Reddy's Laboratories Latest Developments

13.25 Glenmark Pharmaceuticals

13.25.1 Glenmark Pharmaceuticals Company Information

13.25.2 Glenmark Pharmaceuticals Meloxicam Product Offered

13.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Glenmark Pharmaceuticals Main Business Overview

13.25.5 Glenmark Pharmaceuticals Latest Developments

13.26 Teva

13.26.1 Teva Company Information

13.26.2 Teva Meloxicam Product Offered

13.26.3 Teva Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Teva Main Business Overview

13.26.5 Teva Latest Developments

13.27 PuraCap Pharmaceutical

13.27.1 PuraCap Pharmaceutical Company Information

13.27.2 PuraCap Pharmaceutical Meloxicam Product Offered

13.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 PuraCap Pharmaceutical Main Business Overview

13.27.5 PuraCap Pharmaceutical Latest Developments

13.28 TARO

13.28.1 TARO Company Information

13.28.2 TARO Meloxicam Product Offered

13.28.3 TARO Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.28.4 TARO Main Business Overview

13.28.5 TARO Latest Developments

13.29 Lupin Pharmaceuticals

13.29.1 Lupin Pharmaceuticals Company Information

13.29.2 Lupin Pharmaceuticals Meloxicam Product Offered

13.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.29.4 Lupin Pharmaceuticals Main Business Overview

13.29.5 Lupin Pharmaceuticals Latest Developments

13.30 Aurobindo Pharma

13.30.1 Aurobindo Pharma Company Information

13.30.2 Aurobindo Pharma Meloxicam Product Offered

13.30.3 Aurobindo Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2020-2022)

13.30.4 Aurobindo Pharma Main Business Overview

13.30.5 Aurobindo Pharma Latest Developments

13.31 Shanghai Bolinger Ingelheim Pharmaceutical

13.32 Shanghai Zhaohui Pharmaceutical

13.33 Sichuan Shenghe Pharmaceutical

13.34 Ningxia Kangya Pharmaceutical

13.35 Yangtze Pharmaceutical Group

13.36 Kunshan Longdeng Ruidi Pharmaceutical

13.37 Jiangsu Yabang Epson Pharmaceutical

13.38 Jiangsu Feima Pharmaceutical Co. , Ltd

13.39 Zhejiang Xianju Pharmaceutical

13.40 Hainan All Star Pharmaceutical

13.41 Hainan Aomeihua Pharmaceutical

13.42 Hunan Mingrui Pharmaceutical

13.43 Suzhou Sinochem Pharmaceutical

13.44 Qilu Pharmaceutical

13.45 Sichuan Luye Pharmaceutical

13.46 Shandong Xinhua Pharmaceutical

13.47 Guangdong Renkang Pharmaceutical

13.48 Hainan Selike Pharmaceutical

14 Research Findings and Conclusion

List of Tables

Table 1. Meloxicam Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Meloxicam Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Combination Drugs

Table 4. Major Players of Prescribed Drugs

Table 5. Global Meloxicam Sales by Type (2017-2022) & (KG)

Table 6. Global Meloxicam Sales Market Share by Type (2017-2022)

Table 7. Global Meloxicam Revenue by Type (2017-2022) & ($ million)

Table 8. Global Meloxicam Revenue Market Share by Type (2017-2022)

Table 9. Global Meloxicam Sale Price by Type (2017-2022) & (US$/G)

Table 10. Global Meloxicam Sales by Application (2017-2022) & (KG)

Table 11. Global Meloxicam Sales Market Share by Application (2017-2022)

Table 12. Global Meloxicam Revenue by Application (2017-2022)

Table 13. Global Meloxicam Revenue Market Share by Application (2017-2022)

Table 14. Global Meloxicam Sale Price by Application (2017-2022) & (US$/G)

Table 15. Global Meloxicam Sales by Company (2020-2022) & (KG)

Table 16. Global Meloxicam Sales Market Share by Company (2020-2022)

Table 17. Global Meloxicam Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Meloxicam Revenue Market Share by Company (2020-2022)

Table 19. Global Meloxicam Sale Price by Company (2020-2022) & (US$/G)

Table 20. Key Manufacturers Meloxicam Producing Area Distribution and Sales Area

Table 21. Players Meloxicam Products Offered

Table 22. Meloxicam Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Meloxicam Sales by Geographic Region (2017-2022) & (KG)

Table 26. Global Meloxicam Sales Market Share Geographic Region (2017-2022)

Table 27. Global Meloxicam Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Meloxicam Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Meloxicam Sales by Country/Region (2017-2022) & (KG)

Table 30. Global Meloxicam Sales Market Share by Country/Region (2017-2022)

Table 31. Global Meloxicam Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Meloxicam Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Meloxicam Sales by Country (2017-2022) & (KG)

Table 34. Americas Meloxicam Sales Market Share by Country (2017-2022)

Table 35. Americas Meloxicam Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Meloxicam Revenue Market Share by Country (2017-2022)

Table 37. Americas Meloxicam Sales by Type (2017-2022) & (KG)

Table 38. Americas Meloxicam Sales Market Share by Type (2017-2022)

Table 39. Americas Meloxicam Sales by Application (2017-2022) & (KG)

Table 40. Americas Meloxicam Sales Market Share by Application (2017-2022)

Table 41. APAC Meloxicam Sales by Region (2017-2022) & (KG)

Table 42. APAC Meloxicam Sales Market Share by Region (2017-2022)

Table 43. APAC Meloxicam Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Meloxicam Revenue Market Share by Region (2017-2022)

Table 45. APAC Meloxicam Sales by Type (2017-2022) & (KG)

Table 46. APAC Meloxicam Sales Market Share by Type (2017-2022)

Table 47. APAC Meloxicam Sales by Application (2017-2022) & (KG)

Table 48. APAC Meloxicam Sales Market Share by Application (2017-2022)

Table 49. Europe Meloxicam Sales by Country (2017-2022) & (KG)

Table 50. Europe Meloxicam Sales Market Share by Country (2017-2022)

Table 51. Europe Meloxicam Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Meloxicam Revenue Market Share by Country (2017-2022)

Table 53. Europe Meloxicam Sales by Type (2017-2022) & (KG)

Table 54. Europe Meloxicam Sales Market Share by Type (2017-2022)

Table 55. Europe Meloxicam Sales by Application (2017-2022) & (KG)

Table 56. Europe Meloxicam Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Meloxicam Sales by Country (2017-2022) & (KG)

Table 58. Middle East & Africa Meloxicam Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Meloxicam Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Meloxicam Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Meloxicam Sales by Type (2017-2022) & (KG)

Table 62. Middle East & Africa Meloxicam Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Meloxicam Sales by Application (2017-2022) & (KG)

Table 64. Middle East & Africa Meloxicam Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Meloxicam

Table 66. Key Market Challenges & Risks of Meloxicam

Table 67. Key Industry Trends of Meloxicam

Table 68. Meloxicam Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Meloxicam Distributors List

Table 71. Meloxicam Customer List

Table 72. Global Meloxicam Sales Forecast by Region (2023-2028) & (KG)

Table 73. Global Meloxicam Sales Market Forecast by Region

Table 74. Global Meloxicam Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Meloxicam Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Meloxicam Sales Forecast by Country (2023-2028) & (KG)

Table 77. Americas Meloxicam Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Meloxicam Sales Forecast by Region (2023-2028) & (KG)

Table 79. APAC Meloxicam Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Meloxicam Sales Forecast by Country (2023-2028) & (KG)

Table 81. Europe Meloxicam Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Meloxicam Sales Forecast by Country (2023-2028) & (KG)

Table 83. Middle East & Africa Meloxicam Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Meloxicam Sales Forecast by Type (2023-2028) & (KG)

Table 85. Global Meloxicam Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Meloxicam Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Meloxicam Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Meloxicam Sales Forecast by Application (2023-2028) & (KG)

Table 89. Global Meloxicam Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Meloxicam Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Meloxicam Revenue Market Share Forecast by Application (2023-2028)

Table 92. Boehringer Ingelheim Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 93. Boehringer Ingelheim Meloxicam Product Offered

Table 94. Boehringer Ingelheim Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 95. Boehringer Ingelheim Main Business

Table 96. Boehringer Ingelheim Latest Developments

Table 97. Baudax Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 98. Baudax Meloxicam Product Offered

Table 99. Baudax Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 100. Baudax Main Business

Table 101. Baudax Latest Developments

Table 102. Perrigo Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 103. Perrigo Meloxicam Product Offered

Table 104. Perrigo Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 105. Perrigo Main Business

Table 106. Perrigo Latest Developments

Table 107. Recro Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 108. Recro Pharma Meloxicam Product Offered

Table 109. Recro Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 110. Recro Pharma Main Business

Table 111. Recro Pharma Latest Developments

Table 112. Iroko Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 113. Iroko Pharma Meloxicam Product Offered

Table 114. Iroko Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 115. Iroko Pharma Main Business

Table 116. Iroko Pharma Latest Developments

Table 117. Zyla Life Sciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 118. Zyla Life Sciences Meloxicam Product Offered

Table 119. Zyla Life Sciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 120. Zyla Life Sciences Main Business

Table 121. Zyla Life Sciences Latest Developments

Table 122. Axsome Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 123. Axsome Therapeutics Meloxicam Product Offered

Table 124. Axsome Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 125. Axsome Therapeutics Main Business

Table 126. Axsome Therapeutics Latest Developments

Table 127. Orbis Biosciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 128. Orbis Biosciences Meloxicam Product Offered

Table 129. Orbis Biosciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 130. Orbis Biosciences Main Business

Table 131. Orbis Biosciences Latest Developments

Table 132. Cellix Bio Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 133. Cellix Bio Meloxicam Product Offered

Table 134. Cellix Bio Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 135. Cellix Bio Main Business

Table 136. Cellix Bio Latest Developments

Table 137. Ligand Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 138. Ligand Pharma Meloxicam Product Offered

Table 139. Ligand Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 140. Ligand Pharma Main Business

Table 141. Ligand Pharma Latest Developments

Table 142. SEDOR Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 143. SEDOR Pharma Meloxicam Product Offered

Table 144. SEDOR Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 145. SEDOR Pharma Main Business

Table 146. SEDOR Pharma Latest Developments

Table 147. Heron Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 148. Heron Therapeutics Meloxicam Product Offered

Table 149. Heron Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 150. Heron Therapeutics Main Business

Table 151. Heron Therapeutics Latest Developments

Table 152. Pacira BioSciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 153. Pacira BioSciences Meloxicam Product Offered

Table 154. Pacira BioSciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 155. Pacira BioSciences Main Business

Table 156. Pacira BioSciences Latest Developments

Table 157. Sanofi Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 158. Sanofi Meloxicam Product Offered

Table 159. Sanofi Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 160. Sanofi Main Business

Table 161. Sanofi Latest Developments

Table 162. Eurofarma Laboratorio Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 163. Eurofarma Laboratorio Meloxicam Product Offered

Table 164. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 165. Eurofarma Laboratorio Main Business

Table 166. Eurofarma Laboratorio Latest Developments

Table 167. TerSera Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 168. TerSera Therapeutics Meloxicam Product Offered

Table 169. TerSera Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 170. TerSera Therapeutics Main Business

Table 171. TerSera Therapeutics Latest Developments

Table 172. Apotex Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 173. Apotex Meloxicam Product Offered

Table 174. Apotex Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 175. Apotex Main Business

Table 176. Apotex Latest Developments

Table 177. Yung Shin Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 178. Yung Shin Pharmaceutical Meloxicam Product Offered

Table 179. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 180. Yung Shin Pharmaceutical Main Business

Table 181. Yung Shin Pharmaceutical Latest Developments

Table 182. Breckenridge Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 183. Breckenridge Pharmaceutical Meloxicam Product Offered

Table 184. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 185. Breckenridge Pharmaceutical Main Business

Table 186. Breckenridge Pharmaceutical Latest Developments

Table 187. Zydus Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 188. Zydus Pharmaceuticals Meloxicam Product Offered

Table 189. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 190. Zydus Pharmaceuticals Main Business

Table 191. Zydus Pharmaceuticals Latest Developments

Table 192. Unichem Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 193. Unichem Pharmaceuticals Meloxicam Product Offered

Table 194. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 195. Unichem Pharmaceuticals Main Business

Table 196. Unichem Pharmaceuticals Latest Developments

Table 197. Strides Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 198. Strides Pharma Meloxicam Product Offered

Table 199. Strides Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 200. Strides Pharma Main Business

Table 201. Strides Pharma Latest Developments

Table 202. Cipla Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 203. Cipla Meloxicam Product Offered

Table 204. Cipla Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 205. Cipla Main Business

Table 206. Cipla Latest Developments

Table 207. Dr. Reddy's Laboratories Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 208. Dr. Reddy's Laboratories Meloxicam Product Offered

Table 209. Dr. Reddy's Laboratories Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 210. Dr. Reddy's Laboratories Main Business

Table 211. Dr. Reddy's Laboratories Latest Developments

Table 212. Glenmark Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 213. Glenmark Pharmaceuticals Meloxicam Product Offered

Table 214. Glenmark Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 215. Glenmark Pharmaceuticals Main Business

Table 216. Glenmark Pharmaceuticals Latest Developments

Table 217. Teva Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 218. Teva Meloxicam Product Offered

Table 219. Teva Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 220. Teva Main Business

Table 221. Teva Latest Developments

Table 222. PuraCap Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 223. PuraCap Pharmaceutical Meloxicam Product Offered

Table 224. PuraCap Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 225. PuraCap Pharmaceutical Main Business

Table 226. PuraCap Pharmaceutical Latest Developments

Table 227. TARO Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 228. TARO Meloxicam Product Offered

Table 229. TARO Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 230. TARO Main Business

Table 231. TARO Latest Developments

Table 232. Lupin Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 233. Lupin Pharmaceuticals Meloxicam Product Offered

Table 234. Lupin Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 235. Lupin Pharmaceuticals Main Business

Table 236. Lupin Pharmaceuticals Latest Developments

Table 237. Aurobindo Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 238. Aurobindo Pharma Meloxicam Product Offered

Table 239. Aurobindo Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 240. Aurobindo Pharma Main Business

Table 241. Aurobindo Pharma Latest Developments

Table 242. Shanghai Bolinger Ingelheim Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 243. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Product Offered

Table 244. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 245. Shanghai Bolinger Ingelheim Pharmaceutical Main Business

Table 246. Shanghai Bolinger Ingelheim Pharmaceutical Latest Developments

Table 247. Shanghai Zhaohui Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 248. Shanghai Zhaohui Pharmaceutical Meloxicam Product Offered

Table 249. Shanghai Zhaohui Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 250. Shanghai Zhaohui Pharmaceutical Main Business

Table 251. Shanghai Zhaohui Pharmaceutical Latest Developments

Table 252. Sichuan Shenghe Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 253. Sichuan Shenghe Pharmaceutical Meloxicam Product Offered

Table 254. Sichuan Shenghe Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 255. Sichuan Shenghe Pharmaceutical Main Business

Table 256. Sichuan Shenghe Pharmaceutical Latest Developments

Table 257. Ningxia Kangya Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 258. Ningxia Kangya Pharmaceutical Meloxicam Product Offered

Table 259. Ningxia Kangya Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 260. Ningxia Kangya Pharmaceutical Main Business

Table 261. Ningxia Kangya Pharmaceutical Latest Developments

Table 262. Yangtze Pharmaceutical Group Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 263. Yangtze Pharmaceutical Group Meloxicam Product Offered

Table 264. Yangtze Pharmaceutical Group Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 265. Yangtze Pharmaceutical Group Main Business

Table 266. Yangtze Pharmaceutical Group Latest Developments

Table 267. Kunshan Longdeng Ruidi Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 268. Jiangsu Yabang Epson Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 269. Jiangsu Feima Pharmaceutical Co. , Ltd Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 270. Zhejiang Xianju Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 271. Hainan All Star Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 272. Hainan Aomeihua Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 273. Hunan Mingrui Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 274. Suzhou Sinochem Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 275. Qilu Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 276. Sichuan Luye Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 277. Shandong Xinhua Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 278. Guangdong Renkang Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

Table 279. Hainan Selike Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Meloxicam

Figure 2. Meloxicam Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Meloxicam Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Meloxicam Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Meloxicam Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Combination Drugs

Figure 10. Product Picture of Prescribed Drugs

Figure 11. Global Meloxicam Sales Market Share by Type in 2021

Figure 12. Global Meloxicam Revenue Market Share by Type (2017-2022)

Figure 13. Meloxicam Consumed in Rheumatoid Arthritis

Figure 14. Global Meloxicam Market: Rheumatoid Arthritis (2017-2022) & (KG)

Figure 15. Meloxicam Consumed in Osteoarthritis

Figure 16. Global Meloxicam Market: Osteoarthritis (2017-2022) & (KG)

Figure 17. Meloxicam Consumed in Soft Tissue Inflammation

Figure 18. Global Meloxicam Market: Soft Tissue Inflammation (2017-2022) & (KG)

Figure 19. Meloxicam Consumed in Traumatic Pain

Figure 20. Global Meloxicam Market: Traumatic Pain (2017-2022) & (KG)

Figure 21. Meloxicam Consumed in Post-Operative Pain

Figure 22. Global Meloxicam Market: Post-Operative Pain (2017-2022) & (KG)

Figure 23. Meloxicam Consumed in Other

Figure 24. Global Meloxicam Market: Other (2017-2022) & (KG)

Figure 25. Global Meloxicam Sales Market Share by Application (2017-2022)

Figure 26. Global Meloxicam Revenue Market Share by Application in 2021

Figure 27. Meloxicam Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Meloxicam Revenue Market Share by Company in 2021

Figure 29. Global Meloxicam Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Meloxicam Revenue Market Share by Geographic Region in 2021

Figure 31. Global Meloxicam Sales Market Share by Region (2017-2022)

Figure 32. Global Meloxicam Revenue Market Share by Country/Region in 2021

Figure 33. Americas Meloxicam Sales 2017-2022 (KG)

Figure 34. Americas Meloxicam Revenue 2017-2022 ($ Millions)

Figure 35. APAC Meloxicam Sales 2017-2022 (KG)

Figure 36. APAC Meloxicam Revenue 2017-2022 ($ Millions)

Figure 37. Europe Meloxicam Sales 2017-2022 (KG)

Figure 38. Europe Meloxicam Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Meloxicam Sales 2017-2022 (KG)

Figure 40. Middle East & Africa Meloxicam Revenue 2017-2022 ($ Millions)

Figure 41. Americas Meloxicam Sales Market Share by Country in 2021

Figure 42. Americas Meloxicam Revenue Market Share by Country in 2021

Figure 43. United States Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Meloxicam Sales Market Share by Region in 2021

Figure 48. APAC Meloxicam Revenue Market Share by Regions in 2021

Figure 49. China Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Meloxicam Sales Market Share by Country in 2021

Figure 56. Europe Meloxicam Revenue Market Share by Country in 2021

Figure 57. Germany Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Meloxicam Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Meloxicam Revenue Market Share by Country in 2021

Figure 64. Egypt Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Meloxicam Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Meloxicam in 2021

Figure 70. Manufacturing Process Analysis of Meloxicam

Figure 71. Industry Chain Structure of Meloxicam

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390